NYSE:MIAX
NYSE:MIAXCapital Markets

Miami International Holdings (MIAX): Evaluating Valuation Following Strong Recent Share Price Gains

Miami International Holdings (MIAX) is drawing attention as investors take a closer look at its recent stock moves. After a month of double-digit gains, there is fresh interest in how the company’s momentum could impact its valuation. See our latest analysis for Miami International Holdings. Momentum in Miami International Holdings has clearly been building, with a 15% 1-month share price return and a strong 40% year-to-date rise, putting the stock firmly on investors’ radars. While recent...
NasdaqGS:RELL
NasdaqGS:RELLElectronic

Do Richardson Electronics’ (RELL) Earnings Beat and Dividend Signal Enduring Profit Growth?

Richardson Electronics reported its first quarter 2026 results on October 8, 2025, posting sales of US$54.61 million and net income of US$1.91 million, both higher than the same period last year, and reaffirmed its quarterly dividend of US$0.06 per common share and US$0.054 per Class B share. These results reflect both revenue and earnings growth paired with continued shareholder returns, highlighting stronger profitability and an ongoing commitment to dividends. With the earnings growth...
NYSE:DHT
NYSE:DHTOil and Gas

Is There Opportunity in DHT Holdings After Recent 18% Jump in 2025?

Thinking about what to do with DHT Holdings stock right now? You’re hardly alone. For investors, weighing the recent performance and future potential is the name of the game. DHT Holdings hasn’t flown under the radar. After running up an eye-catching 18.0% so far this year, it’s delivered a five-year return of 212.3%. If you zoom in, you’ll see the stock has given back a little ground in the past month, down 7.8%, but that hardly dims the shine of a nearly 80% gain over the last three years...
NYSE:BRO
NYSE:BROInsurance

Does Brown & Brown’s Stock Price Reflect Its Real Value After Recent Soft Results in 2025?

Thinking about what to do with Brown & Brown stock? You are not alone. Investors everywhere are eyeing its recent moves, trying to make sense of where it stands after a decade marked by impressive growth. The past year has not exactly been a rollercoaster, but the trends are worth a closer look. Year to date, shares are down by 6.0%, while the one-year return clocks in at -10.3%. That sounds lukewarm, but take a step back and you will see the bigger picture. Over the last three years, Brown &...
NasdaqGS:GERN
NasdaqGS:GERNBiotechs

The Bull Case For Geron (GERN) Could Change Following Major Executive Appointments—Is a New Era Ahead?

In October 2025, Geron Corporation announced a series of executive changes, including the departures of Andrew Grethlein, Ph.D., and Jim Ziegler, and the appointments of Ahmed ElNawawi as Chief Commercial Officer, Shanthakumar Tyavanagimatt as Chief Technical Officer, Dawn Schottlandt as SVP of Investor Relations and Corporate Affairs, and Bryan Ridgell as SVP of Portfolio and Project Management and Chief of Staff. These significant leadership transitions reflect the company’s intent to...
NasdaqCM:TVRD
NasdaqCM:TVRDPharmaceuticals

Can Early REVERT Data Shape Tvardi Therapeutics' (TVRD) Path in the Pulmonary Fibrosis Market?

On October 13, 2025, Tvardi Therapeutics held a special call to provide an update on preliminary results from its Phase 2 REVERT trial evaluating a therapy for idiopathic pulmonary fibrosis. This update offers critical insight into the company’s research progress on a disease with limited treatment options and high unmet need. We’ll look at how the release of new clinical trial data frames Tvardi Therapeutics’ investment narrative and clinical development outlook. Rare earth metals are the...
NasdaqGS:GEMI
NasdaqGS:GEMICapital Markets

Assessing Gemini Space Station After 26.7% Drop and Regulatory Headlines in 2025

If you have been eyeing Gemini Space Station stock lately, you are not alone. Investors are weighing their options closely, especially after watching the share price close at $23.45. This level has some asking whether the current dip signals opportunity or deeper problems ahead. The stock has slid by 7.3% over the past week, and the 30-day picture is even rougher, showing a drop of 26.7%. That kind of movement catches attention, and it is no wonder many are trying to decide whether now might...
NasdaqCM:ATYR
NasdaqCM:ATYRBiotechs

Should You Reconsider aTyr Pharma After the Recent 17% Price Surge?

Deciding what to do with aTyr Pharma stock right now? You’re definitely not alone. With wild price swings in the rearview mirror, investors are wondering if this is a turnaround story or a value trap in disguise. Over the past week, shares actually jumped by 17.1%, shaking off at least some of the sting from a dramatic slide in the last month, where the stock plunged 84.0%. Year-to-date returns remain deep in the red at -75.3%, and those losses stretch even further if you zoom out: down 56.9%...
NasdaqGS:NTGR
NasdaqGS:NTGRCommunications

NETGEAR (NTGR) Is Up 7.9% After Global SASE Security Launch and Potential TP-Link Restrictions

Earlier this month, NETGEAR announced a new all-in-one SASE and hybrid firewall platform, “Exium,” for small and medium-sized enterprises and Managed Service Providers, developed through a recent acquisition and available globally as of National Cybersecurity Awareness month. Amid this product unveiling, the U.S. government began considering restrictions on Chinese rival TP-Link Systems due to national security concerns, positioning NETGEAR to benefit from reduced competition in the router...